Publications by authors named "Jesus Maria Hernandez-Rivas"

Claim this Profile
M
Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence.
Elvira Mora, María Laura Fox, Angelina Lemes, Beatriz Velasco, Jesús María Hernández-Rivas

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.
Léa Dehgane, Eliane Mallet, Constance Brasseur, Daphné Krzisch, Wail Zeitouni

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.
Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, David A Cairns, Alessandra Larocca

Hemasphere· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.
Lorena Díaz-Ajenjo, Ana Marín-Quílez, Ana Lama-Villanueva, Pablo García-Jaén, Beatriz Rey-Bua

J Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.
Kelly Plueschke, Carla Jonker, Hanna Kankanen, Thorsten Vetter, Bruno Sepodes

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.
Alena Sophie Ehrmann, Miguel Quijada-Álamo, Viola Close, Min Guo, Valentina Carracoi

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.
Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, Ferran Nadeu, Manja Meggendorfer

Leukemia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.
Marta Anna Sobas, Amin T Turki, Angela Villaverde Ramiro, Alberto Hernández-Sánchez, Javier Martinez Elicegui

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients.
Sjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven, Yvette van Norden, Jeroen J W M Janssen

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model.
Ana Marin-Quilez, Ignacio García-Tuñón, Rocío Benito, José Luis Ordoñez, Lorena Díaz-Ajenjo

Biomolecules· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia.
Alberto Rodríguez-Sánchez, Miguel Quijada-Álamo, Claudia Pérez-Carretero, Ana B Herrero, Andrés Arroyo-Barea

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project.
Maria Teresa Voso, Luca Guarnera, Söhren Lehmann, Konstanze Döhner, Hartmut Döhner

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia.
Josgrey Navas-Acosta, Alberto Hernández-Sánchez, Teresa González, Ángela Villaverde Ramiro, Sandra Santos

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.
Irene Pastor-Galán, Arturo Pereira, Eduardo Arellano-Rodrigo, Iván Martín, Adrián Mosquera-Orgueira

Leukemia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
Claudia Pérez Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study.
Alberto Hernández-Sánchez, Teresa González, Marta Sobas, Eric Sträng, Gastone Castellani

Leukemia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial.
María Díez-Campelo, Félix López-Cadenas, Blanca Xicoy, Eva Lumbreras, Teresa González

Lancet Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response.
Mónica Del Rey González, Sohini Chakraborty, Jesús María Hernández-Sánchez, María Diez Campelo, Christopher Y Park

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Alberto Hernández-Sánchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Elias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, Kelly Chien, Monica Del Rey

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology.
Daniele Dall'Olio, Eric Sträng, Amin T Turki, Jesse M Tettero, Martje Barbus

PLoS Comput Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Juan Carlos Caballero, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal

Ther Adv Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
Victoria Del Pozo, Irina Bobolea, Manuel J Rial, Georgina Espigol-Frigolé, Roser Solans Laqué

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project.
Irene Serrano-Gonzalo, Laura López de Frutos, Carlos Lahoz-Gil, Francisco Delgado-Mateos, María Ángeles Fernández-Galán

Orphanet J Rare Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis